Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Piqur Therapeutics closes CHF32mm Series A round; CHF18mm added later

Executive Summary

Biotech start-up Piqur Therapeutics AG closed a two-tranche Series A round at CHF32mm ($36mm). The company opened the financing in January and received CHF14mm, and this month got a CHF18mm extension. New and existing investors participated including Versant Ventures, who led the second closing and invested a total of CHF11mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies